ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 331,85
0,41%
DAX
18 164,06
-0,86%
Brent Oil
86,445
0,00%
Bitcoin
61 503,42
-0,84%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bioenvision (MM) (BIVN)

  7. Bioenvision (MM) (BIVN) Actualités

BIVN

Bioenvision (BIVN)

Bioenvision (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIVN
DateHeureSourceTitreSymboleSociété
11/04/201714h30GlobeNewswire Inc.MonoSol Rx Appoints James S. Scibetta to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
23/10/200723h40PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer IndexNASDAQ:BIVNBioenvision (MM)
22/10/200722h50PR Newswire (US)Bioenvision Shareholders Approve Acquisition by Genzyme CorporationNASDAQ:BIVNBioenvision (MM)
10/10/200720h57PR Newswire (US)Delaware Court Approves Bioenvision, Genzyme Joint PetitionNASDAQ:BIVNBioenvision (MM)
05/10/200723h00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
01/10/200715h17Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
27/09/200714h45PR Newswire (US)Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding ShareNASDAQ:BIVNBioenvision (MM)
27/09/200714h31Edgar (US Regulatory)Bioenvision Inc (Other) (DFAN14A)NASDAQ:BIVNBioenvision (MM)
20/09/200720h15Edgar (US Regulatory)Bioenvision Inc (Other) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
19/09/200723h11Edgar (US Regulatory)Bioenvision Inc (Other)NASDAQ:BIVNBioenvision (MM)
06/09/200715h49PR Newswire (US)Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues CompanyNASDAQ:BIVNBioenvision (MM)
16/08/200714h00Business WireBioenvision Provides Evoltra(R) (clofarabine) Regulatory UpdateNASDAQ:BIVNBioenvision (MM)
28/07/200700h24PR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
26/07/200722h30Business WireBioenvision, Inc. Says Securities Class Action Litigation Without MeritNASDAQ:BIVNBioenvision (MM)
16/07/200715h00Business WireDr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of DirectorsNASDAQ:BIVNBioenvision (MM)
10/07/200720h44PR Newswire (US)/C O R R E C T I O N -- Genzyme Corporation/NASDAQ:BIVN
10/07/200715h27PR Newswire (US)Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
02/07/200716h45PR Newswire (US)Genzyme Extends Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
27/06/200719h30PR Newswire (US)Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
29/05/200716h09PR Newswire (US)Genzyme Corporation to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
08/05/200713h00Business WireBioenvision Reports Third Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
07/05/200713h02Business WireBioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO CapitalNASDAQ:BIVNBioenvision (MM)
03/05/200713h02Business WireBioenvision to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
01/05/200713h02Business WireBioenvision to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, May 8, 2007NASDAQ:BIVNBioenvision (MM)
09/04/200713h02Business WireBioenvision to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
02/04/200712h59Business WireBioenvision Announces Registered Direct Offering of $30 Million in Common StockNASDAQ:BIVNBioenvision (MM)
01/02/200713h00Business WireBioenvision Licenses Its Proprietary Antimicrobial Technology to Foster CorporationNASDAQ:BIVNBioenvision (MM)
31/01/200718h12Business WireBioenvision to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on Thursday, February 8, 2007NASDAQ:BIVNBioenvision (MM)
08/01/200713h00Business WireBioenvision to Present at 25th Annual JPMorgan Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
11/12/200620h59Business WireNew Evoltra(R) Data Shows Impressive Response and Survival RatesNASDAQ:BIVNBioenvision (MM)
 Showing the most relevant articles for your search:NASDAQ:BIVN

Dernières Valeurs Consultées

LSE
44HL
Bp Cap. 26
LSE
FT27
Barclays 29
LSE
51MZ
B.a.t.if 26
LSE
17NN
Barclays 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés